See also this year's filing and all EDGAR filings for this company.
PDF Report 0001343009_2021_CNBX_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001343009, CNBX Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 929,910 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 862,879 |
| 3 | remainder_Assets | 426,522 |
| 4 | LiabilitiesCurrent | 454,787 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,308,150 |
| 9 | ResearchAndDevelopmentExpense | 1,682,462 |
| 10 | remainder_Expenses | 59,997 |
| 11 | remainder_Revenues | 7,157 |
| 12 | remainder_NetIncome | -4,424,012 |
| 13 | remainder_ComprehensiveNetIncome | -5,584,424 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,219,311 |
| 1 | Liabilities | 454,787 |
| 2 | Expenses | 3,050,609 |
| 3 | Revenues | 7,157 |
| 4 | StockholdersEquity | 1,764,524 |
| 5 | NetIncome | -7,467,464 |
| 6 | ComprehensiveNetIncome | -10,259,676 |
| 7 | BaseVar | 7,870,150 |
| 8 | EconomicCapitalRatio | -5.40 |
Edgar->Model Mapping
Feature Distribution
Change over Time
